P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma

P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma

Bibliographic Details
Main Authors:	Andrea Visentin, Edoardo Ruggeri, Federica Frezzato, Marco Pizzi, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavarretta, Valeria Ruocco, Stefano Pravato, Filippo Severin, Monica Facco, Sabrina Manni, Francesci Piazza, Livio Trentin
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000890784.88764.fa

Similar Items

Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course
by: Francesco Angotzi, et al.
Published: (2024-03-01)

P005: Age, histotype and stage IV are associated with a shorter survival in patients with Hodgkin lymphoma, even the PET-adapted era. A single center retrospective study.
by: Andrea Visentin, et al.
Published: (2022-10-01)

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
by: Alessandro Cellini, et al.
Published: (2023-05-01)

P1076: A RETROSPECTIVE ANALYSIS ON OLD AND EMERGING PROGNOSTIC FACTORS IN CLASSICAL HODGKIN’S LYMPHOMA IN THE PET-GUIDED ERA
by: A. Cellini, et al.
Published: (2022-06-01)

From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance
by: Andrea Visentin, et al.
Published: (2022-03-01)

P1075: ADVANCED-STAGE CHL INTERNATIONAL PROGNOSTICATION INDEX: EXTERNAL VALIDATION IN A SINGLE-CENTER RETROSPECTIVE PATIENT DATASET AND COMPARISON TO THE HASENCLEVER IPS
by: Alessandro Cellini, et al.
Published: (2023-08-01)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
by: Zaira Spinello, et al.
Published: (2021-04-01)

P680: SARCOPENIA EVALUATED BY CT SCAN IS ASSOCIATED WITH SHORTER SURVIVAL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH TARGETED THERAPIES. A PROSPECTIVE STUDY.
by: A. Visentin, et al.
Published: (2022-06-01)

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
by: Andrea Visentin, et al.
Published: (2022-12-01)

Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?
by: Nayla Mouawad, et al.
Published: (2023-03-01)

Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia
by: Federica Frezzato, et al.
Published: (2021-10-01)

Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma
by: Sabrina Manni, et al.
Published: (2021-10-01)

Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways
by: Sabrina Manni, et al.
Published: (2017-10-01)

Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases
by: Francesco Angotzi, et al.
Published: (2022-02-01)

IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
by: Francesco Di Raimondo, et al.
Published: (2014-05-01)

P054 (0092) PREGNANCY IN PATIENTS IN COMPLETE REMISSION AFTER HODGKIN LYMPHOMA: CLINICAL FEATURES AND OUTCOME
Published: (2018-10-01)

Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia
by: Mario Angelo Pagano, et al.
Published: (2022-10-01)

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience
by: Francesco Angotzi, et al.
Published: (2024-04-01)

Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma
by: Sabrina Manni, et al.
Published: (2022-08-01)

CK2β-regulated signaling controls B cell differentiation and function
by: Laura Quotti Tubi, et al.
Published: (2023-01-01)

CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis
by: Laura Quotti Tubi, et al.
Published: (2023-12-01)

CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma
by: Anna Fregnani, et al.
Published: (2022-08-01)

Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells.
by: Sabrina Manni, et al.
Published: (2013-01-01)

T001 (0006) Ck2a IS OVEREXPRESSED, ACTIVE AND TARGETABLE WITH SILMITASERTIB IN CLASSICAL HODGKIN LYMPHOMA
Published: (2018-10-01)

Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma.
by: Stefan Nagel, et al.
Published: (2015-01-01)

P054: Creation of the Ontario Hereditary Cancer Research Network (OHCRN)
by: Lauren Hughes, et al.
Published: (2023-01-01)

P054 Molecular characterization and the role of lymphocyte microenvironment in breast cancer
by: K. Ben Hamida, et al.
Published: (2023-03-01)

P1279: INHIBITION OF PROTEIN KINASE CK2 AND BCL-2: A NOVEL THERAPEUTIC STRATEGY TO ANTAGONIZE MANTLE CELL LYMPHOMA CELL GROWTH
by: S. Manni, et al.
Published: (2022-06-01)

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies
by: Francesco Angotzi, et al.
Published: (2023-06-01)

p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB
by: Vanessa Tatangelo, et al.
Published: (2022-06-01)

Glycerophosphoinositol Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells by Enhancing Bax Expression and Activation
by: Gioia Boncompagni, et al.
Published: (2022-03-01)

PB2261: LINEZOLID AS A SAFE ANTIMICROBIAL AGENT IN THROMBOCYTOPENIC PATIENTS UNDERGOING CHEMOTHERAPY FOR HEMATOLOGIC MALIGNANCIES
by: F. Angotzi, et al.
Published: (2022-06-01)

054 CYTOKINE ADSORPTION IN SEPSIS: CORRECT TIMING CAN PREDICT THE FAVORABLE OUTCOME
by: Deepak Govil, et al.
Published: (2017-08-01)

054 An adult case of acute cerebellitis as a manifestation of Mycoplasma Pneumoniae infection
by: Andrew Swayne, et al.
Published: (2021-08-01)

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study
by: Andrea Visentin, et al.
Published: (2022-11-01)

Limbic Encephalitis with HU-Antibodies in T-cell Anaplastic Lymphoma. A Case Report
by: Carmela Gurrieri, et al.
Published: (2021-07-01)

The NKL- and TALE-Codes Represent Hematopoietic Gene Signatures to Evaluate Deregulated Homeobox Genes in Hodgkin Lymphoma
by: Stefan Nagel
Published: (2022-02-01)

A Case of Hemophagocytic Lymphohistiocytosis Triggered by Disseminated Tuberculosis and Hairy Cell Leukaemia after SARS-CoV2 Infection
by: Alessandro Cellini, et al.
Published: (2022-01-01)

Severe Fatal Mucormycosis in a Patient with Chronic Lymphocytic Leukaemia Treated with Zanubrutinib: A Case Report and Review of the Literature
by: Giuseppe Maggioni, et al.
Published: (2023-09-01)

EDGES-3 RFI filter parameters for absorption data 2023_054 to 2023_135
by: Rogers, Alan E.E.
Published: (2024)